1GOODMAN D B.Fundamental principles involved in developing a new saliva-based diagnostic test[J].Ann N Y Acad Sci,1993,694:78.
2LIU H,DELGADO M R,BROWNE R H.Interactions of valproic acid with carbarnazepine and its metabolites concentrations,concentrations ratios,and level/dose ratios in epileptic children[J].Clin Neuropharmacol,1995,18 (1):1.
4GORODISCHER R,BURTIN P,VERJEE Z,et al.Is saliva suitable for therapeutic monitoring of anticonvalsants in children:an evaluation in the routine clinical setting[J].Ther Drug Monit,1997,19 (6):637.
5BARTELS H,GUNTHER E,WAILLIS S.Flow-dependent salivary primidone levels in epileptic children[J].Epilepsia,1989,20(4):431.
6FUNG K,UEDA K.Saliva and serum vaproic acid levels in epileptic children[J].Pediatr,1996,100(3):512.
7RYAN M,GRIM S A,MILES M V,et al.Correlation of lamotrigine concentrations between serum and Saliva[J].Pharmacotherapy,2003,23(12):1550.
8CARDOT J M,DEGEN P,FLESCH G,et al.Comparison of plasma and saliva concentrations of the active monohydroxy metabollte of oxcarbazepine in patients[J].Biopharm Drug Dispos,1995,16 (7):603.
9MILES M V,TANG P H,GLANSER T A,et al.Topiramate concentration in saliva:an alternative to serum monitoring[J].Pediatr Neurol,2003,29(2):143.
二级参考文献11
1Li T，中国医院药学杂志，1998年，18卷，5期，204页
2He S X，Chronopharmacology and Chronotherapy，1998年，68-69,130-155页
